Skip to main content

Advertisement

Log in

A Lifecycle Approach to HIV Prevention in African Women and Children

  • The Global Epidemic (S Vermund, Section Editor)
  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Effective biomedical and structural HIV prevention approaches are being implemented throughout sub-Saharan Africa. A “lifecycle approach” to HIV prevention recognizes the interconnectedness of the health of women, children and adolescents, and prioritizes interventions that have benefits across these populations. We review new biomedical prevention strategies for women, adolescents and children, structural prevention approaches, and new modalities for eliminating infant HIV infection, and discuss the implications of a lifecycle approach for the success of these methods. Some examples of the lifecycle approach include evaluating education and HIV prevention strategies among adolescent girls not only for their role in reducing risk of HIV infection and early pregnancy, but also to promote healthy adolescents who will have healthier future children. Similarly, early childhood interventions such as exclusive breastfeeding not only prevent HIV, but also contribute to better child and adolescent health outcomes. The most ambitious biomedical infant HIV prevention effort, Option B+, also represents a lifecycle approach by leveraging the prevention benefits of optimal HIV treatment for mothers; maternal survival benefits from Option B+ may have ultimately more health impact on children than the prevention of infant HIV in isolation. The potential for synergistic and additive benefits of lifecycle interventions should be considered when scaling up HIV prevention efforts in sub-Saharan Africa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. United Nations. United Nations millenium development goals report 2010. New York, NY; 2010.

  2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399–410.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423–34.

    Article  CAS  PubMed  Google Scholar 

  5. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–74.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Marrazzo JM, Ramjee G, Nair G, Palanee T, Mkhize B, et al. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN-003). 2013 Conference on Retroviruses and Opportunistic Infections. Atlanta, GA; 2013.

  7. Abdool Karim Q, Kharsany AB, Frohlich JA, Werner L, Mlotshwa M, et al. HIV incidence in young girls in KwaZulu-Natal, South Africa–public health imperative for their inclusion in HIV biomedical intervention trials. AIDS Behav. 2012;16:1870–6.

    Article  PubMed  Google Scholar 

  8. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367:411–22.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Friend DR, Kiser PF. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned. Antiviral Res. 2013;99:391–400.

    Article  CAS  PubMed  Google Scholar 

  10. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643–56.

    Article  PubMed  Google Scholar 

  12. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–66.

    Article  PubMed  Google Scholar 

  13. Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, et al. Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys. PLoS Med. 2013;10:e1001509. Using population surveys in an area where circumcision was recently introduced, this study showed durable reductions in HIV prevalence among circumcised men and 19 % lower HIV prevalence than would have been expected without the voluntary male circumcision program.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Centers for Disease Control and Prevention. Progress in voluntary medical male circumcision service provision - Kenya, 2008-2011. MMWR Morb Mortal Wkly Rep. 2012;61:957–61.

    Google Scholar 

  15. Kohler HP, Thornton R. Conditional cash transfers and HIV/AIDS prevention: unconditionally promising? World Bank Econ Rev. 2012;26:165–90.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Baird SJ, Garfein RS, McIntosh CT, Ozler B. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012;379:1320–9.

    Article  PubMed  Google Scholar 

  17. Pettifor A, MacPhail C, Nguyen N, Rosenberg M. Can money prevent the spread of HIV? A review of cash payments for HIV prevention. AIDS Behav. 2012;16:1729–38.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Heise L, Lutz B, Ranganathan M, Watts C. Cash transfers for HIV prevention: considering their potential. J Int AIDS Soc. 2013;16:18615. This paper reviews the available evidence on conditional cash transfers and HIV prevention including recommendations for future research.

    Article  PubMed Central  PubMed  Google Scholar 

  19. de Walque D, Dow WH, Nathan R, Abdul R, Abilahi F, et al. Incentivising safe sex: a randomised trial of conditional cash transfers for HIV and sexually transmitted infection prevention in rural Tanzania. BMJ Open. 2012;2:e000747.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Cowan F, Pettifor A. HIV in adolescents in sub-Saharan Africa. Curr Opin HIV AIDS. 2009;4:288–93.

    Article  PubMed  Google Scholar 

  21. Hardee K, Gay J, Croce-Galis M, Peltz A. Strengthening the enabling environment for women and girls: what is the evidence in social and structural approaches in the HIV response? J Int AIDS Soc. 2014;17:18619.

    Article  PubMed Central  PubMed  Google Scholar 

  22. World Health Organization. Programmatic update: Use of antiretroviral drugs for treating pregnant woman and preventing HIV infection in infants. 2012. This report outlines the rationale for Options B and B+ for prevention of mother-to-child transmission of HIV and describes the benefits to mothers, infants and partners.

  23. Stringer EM, Ekouevi DK, Coetzee D, Tih PM, Creek TL, et al. Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries. JAMA. 2010;304:293–302.

    Article  CAS  PubMed  Google Scholar 

  24. Sibanda EL, Weller IV, Hakim JG, Cowan FM. The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis. AIDS. 2013;27:2787–97. This review pools data from multiple published studies worldwide and shows that HIV-exposed children are highly unlikely to receive all services; based on their estimates, only 20 % of infants are followed to a postnatal test.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Wettstein C, Mugglin C, Egger M, Blaser N, Vizcaya LS, et al. Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis. AIDS. 2012;26:2361–73.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Homsy J, Moore D, Barasa A, Were W, Likicho C, et al. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2010;53:28–35.

    Article  PubMed  Google Scholar 

  27. Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362:2282–94.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Mbori-Ngacha D, Nduati R, John G, Reilly M, Richardson B, et al. Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: a randomized clinical trial. JAMA. 2001;286:2413–20.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Thomas TK, Masaba R, Borkowf CB, Ndivo R, Zeh C, et al. Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding–the Kisumu Breastfeeding Study, Kenya: a clinical trial. PLoS Med. 2011;8:e1001015.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Watts DH, Brown ER, Maldonado Y, Herron C, Chipato T, et al. HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial. J Acquir Immune Defic Syndr. 2013;64:299–306.

    Article  PubMed  Google Scholar 

  31. Centers for Disease Control and Prevention. Impact of an innovative approach to prevent mother-to-child transmission of HIV–Malawi, July 2011-September 2012. MMWR Morb Mortal Wkly Rep. 2013;62:148–51.

    Google Scholar 

  32. Zaba B, Calvert C, Marston M, Isingo R, Nakiyingi-Miiro J, et al. Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA). Lancet. 2013;381:1763–71. Using pooled data from East and Southern Africa, this paper concluded that pregnant and postpartum HIV-infected women experience 8 times the mortality of uninfected women, and predicted that 24 % of maternal death in Africa is attributable to HIV.

    Article  PubMed  Google Scholar 

  33. Moodley J, Pattinson RC, Baxter C, Sibeko S, Abdool Karim Q. Strengthening HIV services for pregnant women: an opportunity to reduce maternal mortality rates in Southern Africa/sub-Saharan Africa. BJOG. 2011;118:219–25.

    Article  CAS  PubMed  Google Scholar 

  34. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach. 2010 Version. Geneva; 2010.

  35. UNAIDS. UNAIDS report on the global HIV epidemic; 2013.

  36. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233–44.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Zunza M, Mercer GD, Thabane L, Esser M, Cotton MF. Effects of postnatal interventions for the reduction of vertical HIV transmission on infant growth and non-HIV infections: a systematic review. J Int AIDS Soc. 2013;16:18865.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Braun M, Kabue MM, McCollum ED, Ahmed S, Kim M, et al. Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2011;56:e122–8.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Ciampa PJ, Burlison JR, Blevins M, Sidat M, Moon TD, et al. Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration. J Acquir Immune Defic Syndr. 2011;58:115–9.

    Article  PubMed  Google Scholar 

  40. Adebimpe WO. Challenges facing early infant diagnosis of HIV among infants in resource poor settings. Afr J Reprod Health. 2013;17:122–9.

    PubMed  Google Scholar 

  41. Chi BH, Bolton-Moore C, Holmes CB. Prevention of mother-to-child HIV transmission within the continuum of maternal, newborn, and child health services. Curr Opin HIV AIDS. 2013;8:498–503.

    Article  PubMed  Google Scholar 

  42. Ghadrshenas A, Ben Amor Y, Chang J, Dale H, Sherman G, et al. Improved access to early infant diagnosis is a critical part of a child-centric prevention of mother-to-child transmission agenda. AIDS. 2013;27 Suppl 2:S197–205.

    Article  PubMed  Google Scholar 

  43. UNAIDS. AIDS by the numbers; 2013.

  44. Nyberg BJ, Yates DD, Lovich R, Coulibaly-Traore D, Sherr L, et al. Saving lives for a lifetime: supporting orphans and vulnerable children impacted by HIV/AIDS. J Acquir Immune Defic Syndr. 2012;60 Suppl 3:S127–35.

    Article  PubMed  Google Scholar 

  45. Amoako Johnson F, Padmadas SS, Smith PW. Orphanhood and vulnerability: a conduit to poor child health outcomes in Rwanda. AIDS Care. 2010;22:314–23.

    Article  PubMed  Google Scholar 

  46. Kinuthia J, Kiarie JN, Farquhar C, Richardson B, Nduati R, et al. Cofactors for HIV-1 incidence during pregnancy and postpartum period. Curr HIV Res. 2010;8:510–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Moodley D, Esterhuizen T, Reddy L, Moodley P, Singh B, et al. Incident HIV infection in pregnant and lactating women and its effect on mother-to-child transmission in South Africa. J Infect Dis. 2011;203:1231–4.

    Article  PubMed  Google Scholar 

  48. Theron GB, Shapiro DE, Van Dyke R, Cababasay MP, Louw J, et al. Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa. Int J Gynaecol Obstet. 2011;113:44–9.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Humphrey JH, Marinda E, Mutasa K, Moulton LH, Iliff PJ, et al. Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study. BMJ. 2010;341:c6580.

    Article  PubMed Central  PubMed  Google Scholar 

  50. Alkema L, Kantorova V, Menozzi C, Biddlecom A. National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis. Lancet. 2013;381:1642–52.

    Article  PubMed  Google Scholar 

  51. Darroch JE, Singh S. Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys. Lancet. 2013;381:1756–62. This review analyzes national data on contraceptive use in 2003, 2008 and 2012 including both married and unmarried women, and concludes ongoing high unmet need for contraception, especially in sub-Saharan Africa.

    Article  PubMed  Google Scholar 

  52. Heffron R, Donnell D, Rees H, Celum C, Mugo N, et al. (2011) Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis.

  53. Polis CB, Phillips SJ, Curtis KM. Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS. 2013;27:493–505.

    Article  CAS  PubMed  Google Scholar 

  54. Polis CB, Curtis KM. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis. 2013;13:797–808.

    Article  PubMed  Google Scholar 

  55. Stuart GS. Fourteen million women with limited options: HIV/AIDS and highly effective reversible contraception in sub-Saharan Africa. Contraception. 2009;80:412–6.

    Article  PubMed  Google Scholar 

  56. Peltzer K, Chao LW, Dana P. Family planning among HIV positive and negative prevention of mother to child transmission (PMTCT) clients in a resource poor setting in South Africa. AIDS Behav. 2009;13:973–9.

    Article  PubMed  Google Scholar 

  57. Jhangri GS, Heys J, Alibhai A, Rubaale T, Kipp W. Unmet need for effective family planning in HIV-infected individuals: results from a survey in rural Uganda. J Fam Plann Reprod Health Care. 2012;38:23–9.

    Article  PubMed  Google Scholar 

  58. Leslie JA, Munyambanza E, Adamchak SE, Janowitz B, Grey TW, et al. Without strong integration of family planning into PMTCT services in Rwanda, clients remain with a high unmet need for effective family planning. Afr J Reprod Health. 2010;14:144–6.

    PubMed  Google Scholar 

  59. Harrington EK, Newmann SJ, Onono M, Schwartz KD, Bukusi EA, et al. Fertility intentions and interest in integrated family planning services among women living with HIV in Nyanza Province, Kenya: a qualitative study. Infect Dis Obstet Gynecol. 2012;2012:809682.

    Article  PubMed Central  PubMed  Google Scholar 

  60. Schwartz SR, Rees H, Mehta S, Venter WD, Taha TE, et al. High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One. 2012;7:e36039.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Wilcher R, Hoke T, Adamchak SE, Cates Jr W. Integration of family planning into HIV services: a synthesis of recent evidence. AIDS. 2013;27 Suppl 1:S65–75.

    Article  PubMed  Google Scholar 

  62. Wilcher R, Petruney T, Cates W. The role of family planning in elimination of new pediatric HIV infection. Curr Opin HIV AIDS. 2013;8:490–7.

    Article  PubMed  Google Scholar 

  63. Chang LW, Serwadda D, Quinn TC, Wawer MJ, Gray RH, et al. Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects. Lancet Infect Dis. 2013;13:65–76.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Vermund SH, Hayes RJ. Combination prevention: new hope for stopping the epidemic. Curr HIV/AIDS Rep. 2013;10:169–86.

    Article  PubMed Central  PubMed  Google Scholar 

  65. Alsallaq RA, Baeten JM, Celum CL, Hughes JP, Abu-Raddad LJ, et al. Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PLoS One. 2013;8:e54575.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  66. Gounder CR, Chaisson RE. A diagonal approach to building primary healthcare systems in resource-limited settings: women-centred integration of HIV/AIDS, tuberculosis, malaria, MCH and NCD initiatives. Trop Med Int Health. 2012;17:1426–31.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This paper benefitted greatly from discussions held as part of the multidisciplinary University of Washington Center for the Integrated Health of Women, Adolescents and Children (Global WACh), a joint effort led by the Departments of Global Health, Pediatrics, and Obstetrics and Gynecology.

Funding

ACR: is supported by K23 HD071788-01A1 from the National Institute of Child Health and Development (NICHD), and by a New Investigator Award from the University of Washington (UW) Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757), which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA). JAU: is supported by K12 HD09026 (NICHD) and by UW CFAR. JAS: is supported by K01 AI087369 from the National Institute of Allergy and Infectious Diseases (NIAID), the Royalty Research Fund, and a New Investigator Award from the UW CFAR. JK: is supported by P01 AI082976-01 and R01-HD075108 (NIAID), and 1R24TW008907 (NIH). GJS: is supported by K24 HD054314 and R01 HD023412-21 (NICHD), and P01 AI082976-01 (NIAID). JLW: is supported by U19 AI 090882 (NIAID) and by awards from the Bill & Melinda Gates Foundation.

Compliance with Ethics Guidelines

Conflict of Interest

Alison C. Roxby, Jennifer A. Unger, Jennifer A. Slyker, John Kinuthia, Andrew Lewis, Grace John-Stewart, and Judd L. Walson declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alison C. Roxby.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roxby, A.C., Unger, J.A., Slyker, J.A. et al. A Lifecycle Approach to HIV Prevention in African Women and Children. Curr HIV/AIDS Rep 11, 119–127 (2014). https://doi.org/10.1007/s11904-014-0203-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-014-0203-2

Keywords

Navigation